HK1065713A1 - Sustained release hgf hydrogel preparations - Google Patents

Sustained release hgf hydrogel preparations

Info

Publication number
HK1065713A1
HK1065713A1 HK04108623.4A HK04108623A HK1065713A1 HK 1065713 A1 HK1065713 A1 HK 1065713A1 HK 04108623 A HK04108623 A HK 04108623A HK 1065713 A1 HK1065713 A1 HK 1065713A1
Authority
HK
Hong Kong
Prior art keywords
sustained release
hydrogel preparations
hgf
release hgf
hydrogel
Prior art date
Application number
HK04108623.4A
Other languages
English (en)
Inventor
Yasuhiko Tabata
Original Assignee
Medgel Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19052974&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1065713(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Medgel Corp filed Critical Medgel Corp
Publication of HK1065713A1 publication Critical patent/HK1065713A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1833—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
HK04108623.4A 2001-07-18 2004-11-02 Sustained release hgf hydrogel preparations HK1065713A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001218870 2001-07-18
PCT/JP2002/007155 WO2003007982A1 (fr) 2001-07-18 2002-07-15 Preparations d'hydrogel hgf a liberation prolongee

Publications (1)

Publication Number Publication Date
HK1065713A1 true HK1065713A1 (en) 2005-03-04

Family

ID=19052974

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04108623.4A HK1065713A1 (en) 2001-07-18 2004-11-02 Sustained release hgf hydrogel preparations

Country Status (7)

Country Link
US (1) US20040253294A1 (fr)
EP (1) EP1415663B1 (fr)
JP (1) JP4878730B2 (fr)
DE (1) DE60229399D1 (fr)
HK (1) HK1065713A1 (fr)
TW (1) TWI319711B (fr)
WO (1) WO2003007982A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004115413A (ja) * 2002-09-25 2004-04-15 Yasuhiko Tabata 冠状動脈狭窄または閉塞治療用徐放性製剤
JP4459543B2 (ja) * 2003-03-17 2010-04-28 株式会社メドジェル 徐放性ハイドロゲル製剤
WO2004089400A1 (fr) * 2003-04-01 2004-10-21 Yasuhiko Tabata Medicament contre la cardiomyopathie
WO2004089401A1 (fr) * 2003-04-01 2004-10-21 Yasuhiko Tabata Medicament contre l'ischemie
US20070142279A1 (en) * 2004-03-09 2007-06-21 Hiroshi Kubo Agent for promoting induction of vascular differentiation, comprising hepatocyte growth factor
US7919112B2 (en) * 2004-08-26 2011-04-05 Pathak Holdings, Llc Implantable tissue compositions and method
WO2006046584A1 (fr) * 2004-10-26 2006-05-04 Santen Pharmaceutical Co., Ltd. Remède pour des traumatismes de cellules visuelles
JP4685090B2 (ja) * 2005-02-14 2011-05-18 株式会社メドジェル 医療用ハイドロゲル
DE102005054937A1 (de) * 2005-11-17 2007-05-24 Gelita Ag Angiogenese förderndes Substrat
DE102007024239A1 (de) * 2007-05-16 2008-11-20 Gelita Ag Angiogenese förderndes Substrat
DE102007051059B4 (de) * 2007-10-18 2014-04-03 NMI Naturwissenschaftliches und Medizinisches Institut an der Universität Tübingen Bioverbundmaterial für die kontrollierte Freisetzung von Wirkstoffen
JP5248519B2 (ja) 2007-11-07 2013-07-31 小野薬品工業株式会社 Ｓｄｆ−１を含有してなる徐放性組成物
MY148573A (en) * 2009-05-15 2013-04-30 Univ Sains Malaysia A method to differentiate the gelatin capsule of the porcine source from the bovine source
US8895508B2 (en) 2009-07-24 2014-11-25 Yasuhiki Tabata Methods for corneal endothelial proliferation using bFGF sustained-release gelatin hydrogel particles
CA2849472A1 (fr) * 2013-04-22 2014-10-22 Nitto Denko Corporation Soutien de gelatine reticule et soutien pour liberation controlee d'une substance physiologiquement active utilisant celui-ci
CN104593779B (zh) * 2015-01-21 2018-02-16 北京科技大学 一种低pH可控释放的智能缓蚀剂的制备方法
CN107374662B (zh) * 2017-07-31 2020-12-18 东软医疗系统股份有限公司 一种放射源制备及相关方法、放射源及pet系统

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5059213A (en) * 1990-03-26 1991-10-22 United States Surgical Corporation Spiroid braided suture
JP3977452B2 (ja) * 1995-02-27 2007-09-19 敏一 中村 動脈疾患治療剤
CA2218145C (fr) * 1997-04-14 2008-01-08 Toshikazu Nakamura Methode de traitement de la cardiomyopathie hypertrophique
DE60009525T2 (de) * 1999-09-30 2005-02-03 Kaken Pharmaceutical Co., Ltd. Herstellung eines medikamentes zur verbesserten heilung des sternums nach einer sternotomie
EP1223959B1 (fr) * 1999-10-22 2007-05-23 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Inhibition de la motilite cellulaire et de l'angiogenese par les inhibiteurs du domaine grb2 sh2

Also Published As

Publication number Publication date
US20040253294A1 (en) 2004-12-16
DE60229399D1 (de) 2008-11-27
EP1415663A4 (fr) 2006-06-07
JP4878730B2 (ja) 2012-02-15
TWI319711B (en) 2010-01-21
WO2003007982A1 (fr) 2003-01-30
EP1415663A1 (fr) 2004-05-06
JPWO2003007982A1 (ja) 2004-11-04
EP1415663B1 (fr) 2008-10-15

Similar Documents

Publication Publication Date Title
IL159048A0 (en) Sustained release formulation
HK1068812A1 (en) Drug preparations
GB0119062D0 (en) Interferometer
HK1065713A1 (en) Sustained release hgf hydrogel preparations
DE60215145D1 (en) Sulfonamide
IL157845A0 (en) Anti-epileptogenic agents
IL160539A0 (en) Anti-influenzal agents
AU148977S (en) Trolley
AU146413S (en) Trolley
GB0108534D0 (en) Retaining means
PL366941A1 (en) Lifting system
AU2002318523A1 (en) Sustained release hgf hydrogel preparations
GB0106987D0 (en) Immunotherapeuitic agent
GB0122162D0 (en) Agent
GB0115893D0 (en) Formulations
GB0129243D0 (en) Hairdryer
GB0103065D0 (en) Interferometer
GB2376939B (en) Retaining means
GB2373761B (en) Haynet Trolley
GB0103066D0 (en) Interferometer
AU1979P (en) KLEC00069 Calibrachoa hybrid
AU1980P (en) KLEC00070 Calibrachoa hybrid
AU1981P (en) KLEC00078 Calibrachoa hybrid
AU1982P (en) KLEC01088 Calibrachoa hybrid
AU2477P (en) Sunbelkist Calibrachoa hybrid

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20130715